Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Financial Results PresentationFirst quarter of the fiscal year ending March 202712 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥12,941 million-3.7%
Operating profit¥1,224 million+6.4%
Ordinary income¥1,592 million+7.6%
Net income¥1,315 million-35.9%
Results for the three months of the current quarter
Net Sales
¥12,941 million
Operating profit
¥1,224 million
Ordinary income
¥1,592 million
Profit attributable to owners of parent for the quarter
¥1,315 million
Full-year earnings forecast
Net Sales
¥52,200 million
Operating profit
¥4,050 million
Ordinary income
¥5,150 million
Net income for the current fiscal year
¥3,900 million
ROE8.0～10.0％
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Increase in Sales¥71 million
- Changes in selling prices¥280 million
- Raw material price fluctuations¥-284 million
- Expense reductions, foreign exchange translation and other factors¥7 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate
156 JPY/USD
Raw Material PricesRaw material prices derived from crude oil are expected to rise, but the figure is not disclosed
New initiatives
- Mass production of CDTS, a high-purity cyclodextrin derivative
- Joint research and development with the Railway Technical Research Institute on lubricants for rails and wheels
- Strategic shift toward using external resources for the construction of a new CD derivative plant
- Strengthening investor relations and shareholder relations activities through the establishment of an IR department
Key KPIsA metric the company considers important as a management benchmark.
- ROE (fiscal year ended March 2026 actual)10.5 ％
- PBR (fiscal 2025)0.6 times
- PER (fiscal 2025)8.3 times
- Regional sales mix_Japan38 ％
- Regional sales mix_North and South America44 ％
Segment results
- JapanNet Sales¥5,423 million (YoY +12.5%)Operating profit¥424 million (YoY +185.1%)
- North and South AmericaNet Sales¥5,475 million (YoY +3.1%)Operating profit¥662 million (YoY -19.4%)
- Southeast Asia/IndiaNet Sales¥2,041 million (YoY +12.5%)Operating profit¥283 million (YoY +23.5%)
- ChinaNet SalesOutside the scope of consolidationOperating profitOutside the scope of consolidation
Medium-term management plan targets
ROEMaintain ROE at a stable level of at least 10%
Operating cash flow during the medium-term management plan period
¥132 million
Financial targets
ROE targetAt least 10%
Actual ROE10.5％
Payout Ratio Target30% or more
Number of employees
Standalone362 People
Consolidated862 People
Record dateAs of the end of March 2026
Capital expenditures
¥52 million
Annual Dividend
Interim Dividend
¥40 per share
Year-end dividendTo be determined
Annual DividendTo be determined
Payout ratio
30% or more
Acquisition of treasury shares
Actual results
¥10 million
Future policyFlexible share repurchases in response to the business environment
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥12,941 million (YoY -3.7%) |
| Operating profit | ¥1,224 million (YoY +6.4%) |
| Ordinary income | ¥1,592 million (YoY +7.6%) |
| Net income | ¥1,315 million (YoY -35.9%) |
| Results for the three months of the current quarter | Net Sales ¥12,941 million / Operating profit ¥1,224 million / Ordinary income ¥1,592 million / Profit attributable to owners of parent for the quarter ¥1,315 million |
| Full-year earnings forecast | Net Sales ¥52,200 million / Operating profit ¥4,050 million / Ordinary income ¥5,150 million / Net income for the current fiscal year ¥3,900 million / ROE 8.0～10.0％ |
| Segment results | Segment Japan / Net Sales ¥5,423 million (YoY +12.5%) / Operating profit ¥424 million (YoY +185.1%), Segment North and South America / Net Sales ¥5,475 million (YoY +3.1%) / Operating profit ¥662 million (YoY -19.4%), Segment Southeast Asia/India / Net Sales ¥2,041 million (YoY +12.5%) / Operating profit ¥283 million (YoY +23.5%), Segment China / Net Sales Outside the scope of consolidation / Operating profit Outside the scope of consolidation |
| Breakdown of Factors Affecting the Change | Factors Increase in Sales / Amount ¥71 million, Factors Changes in selling prices / Amount ¥280 million, Factors Raw material price fluctuations / Amount ¥-284 million, Factors Expense reductions, foreign exchange translation and other factors / Amount ¥7 million |
| Key KPIs | Indicator name ROE (fiscal year ended March 2026 actual) / Value 10.5 ％ / Year on year against the same period last year Not disclosed, Indicator name PBR (fiscal 2025) / Value 0.6 times / Year on year against the same period last year Not disclosed, Indicator name PER (fiscal 2025) / Value 8.3 times / Year on year against the same period last year Not disclosed, Indicator name Regional sales mix_Japan / Value 38 ％ / Year on year against the same period last year Not disclosed, Indicator name Regional sales mix_North and South America / Value 44 ％ / Year on year against the same period last year Not disclosed |
| Number of employees | Standalone 362 People / Consolidated 862 People / Record date As of the end of March 2026 |
| Assumptions Underlying the Business Outlook | Exchange rate 156 JPY/USD / Raw Material Prices Raw material prices derived from crude oil are expected to rise, but the figure is not disclosed |
| Medium-term management plan targets | ROE Maintain ROE at a stable level of at least 10% / Operating cash flow during the medium-term management plan period ¥132 million |
| Financial targets | ROE target At least 10% / Actual ROE 10.5％ / Payout Ratio Target 30% or more |
| Annual Dividend | Interim Dividend ¥40 per share / Year-end dividend To be determined / Annual Dividend To be determined |
| Payout ratio | 30% or more |
| Acquisition of treasury shares | Actual results ¥10 million / Future policy Flexible share repurchases in response to the business environment |
| Capital expenditures | ¥52 million |
| New initiatives | Mass production of CDTS, a high-purity cyclodextrin derivative, Joint research and development with the Railway Technical Research Institute on lubricants for rails and wheels, Strategic shift toward using external resources for the construction of a new CD derivative plant, Strengthening investor relations and shareholder relations activities through the establishment of an IR department |
Items this document does not state (11)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsRisk amount incorporated into the outlookOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although selling prices were revised and demand remained firm, net sales declined due to the impact of transferring Shanghai 尤希路化学工業有限公司 in China from a consolidated subsidiary to an equity-method affiliate. Operating income increased due to the effects of price revisions and cost controls, while ordinary income increased due to higher operating income and increased share of profit of investments accounted for using the equity method. Quarterly net income declined mainly because gains on the sale of investment securities recorded in the same quarter of the previous year were absent.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.